Efficacy and Safety of Bevacizumab (Avastin®) Combined to Weekly Paclitaxel Followed by Bevacizumab (Avastin®) Alone in Patients With Relapsed Ovarian Sex-cord Stromal Tumours (ALIENOR)

This study is currently recruiting participants. (see Contacts and Locations)
Verified April 2013 by ARCAGY/ GINECO GROUP
Sponsor:
Collaborator:
Roche Pharma AG
Information provided by (Responsible Party):
ARCAGY/ GINECO GROUP
ClinicalTrials.gov Identifier:
NCT01770301
First received: January 15, 2013
Last updated: April 4, 2013
Last verified: April 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: January 2021
  Estimated Primary Completion Date: June 2016 (Final data collection date for primary outcome measure)